Login / Signup

Clinical Evidence and Practice-Based Guidelines on the Utility of Basal insulin combined Oral therapy (metformin and glimepiride) in the current era.

Abhishek ShrivastavaJothydev KesavadevViswanathan MohanBanshi SabooDina ShresthaAnuj MaheshwariBrij Mohan MakkarKirtikumar D ModiAshok Kumar Das
Published in: Current diabetes reviews (2023)
These current clinical practice guidelines highlight the efficacy and safety of basal insulin combination therapy with various available basal insulins including neutral protamine hagedorn, detemir, glargine and degludec in addition to metformin and glimepiride therapy.
Keyphrases
  • combination therapy
  • type diabetes
  • glycemic control
  • primary care
  • healthcare
  • stem cells
  • clinical practice
  • metabolic syndrome
  • insulin resistance
  • quality improvement
  • skeletal muscle
  • cell therapy